Michael Lamson

Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.

R. Murphy, M. Myers, J. Sommadossi, 1999, The Journal of infectious diseases.

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection.

T. Greenough, D. Havlir, S. Spector, 1995, The Journal of infectious diseases.

Disposition and biotransformation of the antiretroviral drug nevirapine in humans.

T. Macgregor, J. Keirns, M. Lamson, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Pharmacokinetics, safety, and activity of nevirapine in human immunodeficiency virus type 1-infected children.

J. Sullivan, K. Luzuriaga, Y. Bryson, 1996, The Journal of infectious diseases.